13D Management LLC Acquires New Position in Integer Holdings Corporation $ITGR

13D Management LLC bought a new position in Integer Holdings Corporation (NYSE:ITGRFree Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 47,000 shares of the medical equipment provider’s stock, valued at approximately $3,686,000. Integer accounts for approximately 4.4% of 13D Management LLC’s portfolio, making the stock its 14th largest position.

Other institutional investors also recently bought and sold shares of the company. Persistent Asset Partners Ltd purchased a new position in shares of Integer during the 4th quarter worth about $320,000. Squarepoint Ops LLC boosted its holdings in shares of Integer by 31.9% in the 4th quarter. Squarepoint Ops LLC now owns 76,795 shares of the medical equipment provider’s stock valued at $6,023,000 after purchasing an additional 18,579 shares during the last quarter. Verition Fund Management LLC grew its stake in shares of Integer by 839.4% during the 4th quarter. Verition Fund Management LLC now owns 68,998 shares of the medical equipment provider’s stock valued at $5,412,000 after buying an additional 61,653 shares during the period. Mariner LLC grew its stake in shares of Integer by 66.6% during the 4th quarter. Mariner LLC now owns 10,377 shares of the medical equipment provider’s stock valued at $814,000 after buying an additional 4,148 shares during the period. Finally, Focus Partners Wealth increased its holdings in shares of Integer by 117.2% during the 4th quarter. Focus Partners Wealth now owns 69,888 shares of the medical equipment provider’s stock worth $5,481,000 after buying an additional 37,712 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Trading Up 0.4%

NYSE:ITGR opened at $91.17 on Wednesday. Integer Holdings Corporation has a one year low of $62.00 and a one year high of $123.78. The business’s 50-day simple moving average is $88.61 and its 200 day simple moving average is $84.49. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75. The stock has a market cap of $3.10 billion, a price-to-earnings ratio of 22.74, a price-to-earnings-growth ratio of 2.16 and a beta of 0.66.

Integer (NYSE:ITGRGet Free Report) last announced its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a return on equity of 12.83% and a net margin of 7.64%.The company had revenue of $439.58 million for the quarter, compared to analyst estimates of $426.48 million. During the same period in the prior year, the business earned $1.31 earnings per share. Integer’s revenue was up .5% on a year-over-year basis. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. As a group, sell-side analysts predict that Integer Holdings Corporation will post 6.04 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Wells Fargo & Company boosted their price target on Integer from $72.00 to $84.00 and gave the company an “equal weight” rating in a research report on Friday, February 20th. Weiss Ratings upgraded Integer from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, February 24th. Zacks Research lowered Integer from a “hold” rating to a “strong sell” rating in a research note on Monday, May 11th. Truist Financial increased their target price on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Friday, February 20th. Finally, Piper Sandler restated an “overweight” rating and issued a $97.00 price target (up from $87.00) on shares of Integer in a report on Friday, May 1st. Four equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Integer currently has a consensus rating of “Hold” and an average price target of $98.71.

Get Our Latest Stock Report on ITGR

About Integer

(Free Report)

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.

Featured Stories

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGRFree Report).

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.